Innate Pharma SA Financial Liabilities
Innate Pharma SA (IPHA) had Financial Liabilities of EUR 22.57 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:FinancialLiabilities · last filed 2026-04-01
- 2025-12-31: Financial Liabilities 22.57M EUR.
- 2025-06-30: Financial Liabilities 27.03M EUR.
- 2024-12-31: Financial Liabilities 31.00M EUR.
- 2024-06-30: Financial Liabilities 35.50M EUR.
| Period end | Financial Liabilities | Financial Liabilities as first filed |
|---|---|---|
| 2025-12-31 | 22.57M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 27.03M EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | 31.00M EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 35.50M EUR 6-K · filed 2025-09-17 | |
| 2023-12-31 | 39.89M EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | 40.66M EUR 6-K · filed 2024-09-12 | |
| 2022-12-31 | 42.25M EUR 20-F · filed 2026-04-01 | |
| 2022-06-30 | 43.37M EUR 6-K · filed 2023-09-14 | |
| 2021-12-31 | 44.25M EUR 20-F · filed 2025-04-30 | |
| 2021-06-30 | 16.50M EUR 6-K · filed 2022-09-15 | |
| 2020-12-31 | 19.09M EUR 20-F · filed 2024-04-04 | |
| 2020-06-30 | 18.82M EUR 6-K · filed 2021-09-15 | |
| 2019-12-31 | 18.72M EUR 20-F · filed 2023-04-06 | |
| 2019-01-01 | 5.69M EUR 20-F · filed 2021-04-27 | |
| 2018-12-31 | 5.69M EUR 20-F · filed 2022-04-04 | 4.52M EUR 20-F · filed 2020-04-24 |
| 2017-12-31 | 5.86M EUR 20-F · filed 2021-04-27 | |
| 2016-12-31 | 5.33M EUR 20-F · filed 2020-04-24 |